Abstract
A single nifurtimox administration to male mice orally (p.o.) (600–2000 mg/kg) but not intrapertitoneally (i.p.) was able to increase micronucleus formation in bone marrow significantly. No significant increase in micronucleus formation in the bone marrow of mice treated with benznidazole at dosages up to 2000 mg/kg, either p.o. or i.p., was observed. The potential mutagenic risk of nifurtimox treatment in patients suffering from Chagas' disease is analyzed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
